I bailed on this company over 3 years ago. Stock was in the mid to high 200’s then. Nothing but a death spiral since. When BS was hired the stock price exploded for a couple years as he bought and merged companies. That was a facade. Nothing new was created. Market Cap was being driven through consolidation of expenses and far too many people buying into BS’s crap about “growth pharma” and “bold” visions. Well, the house of cards has collapsed. If you never create or build anything new the market will not raise your company’s value. This was totally predictable, and for those of us who didn’t drink the coolaid we did ok - we jumped off the sinking ship and sold our overvalued options at inflated prices. Many even received a severance package for doing so. For those of you who remained, I do admit you have a decent salary and good benefits, so not all was lost. But people like working for winners. Allergen and BS clearly are not winners.
Agree....This drip drip drip has to stop. Board has to do its job and Saunders needs to go. Saunders and his cronies have single handedly destroyed the company. Most of the recent acquisitions have been non-sensical and failures.
Why are we rewarding Saunders performance with continued employment? Would any other position be given the same allowance for such failure?
let me get this right.... BS burned well over $100BB on mergers and acquisitions since 2015. Granted, he sold off the generics for just over $30BB, so let’s conservatively call it $70BB. Market cap of AGN at the CoB today (June 17, 2019): $37.94BB SMH..... How does he survive?
The stock price will be depressed until Brent packs it in. The hard work will begin after that. Until that happens only pain.
